PFIZER Stock Overview
Pfizer Limited engages in manufacturing, marketing, trading, and export of pharmaceutical products in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Pfizer Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹4,304.80 |
| 52 Week High | ₹5,000.00 |
| 52 Week Low | ₹3,690.00 |
| Beta | 0.32 |
| 1 Month Change | 1.83% |
| 3 Month Change | -1.28% |
| 1 Year Change | 13.52% |
| 3 Year Change | -19.48% |
| 5 Year Change | 44.02% |
| Change since IPO | 205.63% |
Recent News & Updates
Recent updates
Pfizer (NSE:PFIZER) Has A Pretty Healthy Balance Sheet
Feb 13
Pfizer Limited's (NSE:PFIZER) Business Is Yet to Catch Up With Its Share Price
Jan 17Here's Why Pfizer (NSE:PFIZER) Can Manage Its Debt Responsibly
Mar 15A Look At The Intrinsic Value Of Pfizer Limited (NSE:PFIZER)
Jul 20Pfizer (NSE:PFIZER) Could Easily Take On More Debt
Mar 29Calculating The Fair Value Of Pfizer Limited (NSE:PFIZER)
Feb 07These 4 Measures Indicate That Pfizer (NSE:PFIZER) Is Using Debt Safely
Sep 23This Is The Reason Why We Think Pfizer Limited's (NSE:PFIZER) CEO Deserves A Bump Up To Their Compensation
Aug 12Are Institutions Heavily Invested In Pfizer Limited's (NSE:PFIZER) Shares?
Mar 10Why Dividend Hunters Love Pfizer Limited (NSE:PFIZER)
Feb 17Are Pfizer's (NSE:PFIZER) Statutory Earnings A Good Guide To Its Underlying Profitability?
Feb 02Need To Know: Pfizer Limited (NSE:PFIZER) Insiders Have Been Buying Shares
Jan 18
Is Pfizer Limited's (NSE:PFIZER) Stock's Recent Performance A Reflection Of Its Financial Health?
Jan 03What Can We Learn About Pfizer's (NSE:PFIZER) CEO Compensation?
Dec 18Here's What Pfizer Limited's (NSE:PFIZER) Shareholder Ownership Structure Looks Like
Dec 03Did You Participate In Any Of Pfizer's (NSE:PFIZER) Fantastic 174% Return ?
Nov 18Are Pfizer's (NSE:PFIZER) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Nov 03Need To Know: Pfizer Limited (NSE:PFIZER) Insiders Have Been Buying Shares
Oct 20Pfizer Limited's (NSE:PFIZER) Stock Is Going Strong: Is the Market Following Fundamentals?
Oct 02Why Pfizer's (NSE:PFIZER) CEO Pay Matters
Sep 17Shareholder Returns
| PFIZER | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 0.6% | -3.4% | -3.7% |
| 1Y | 13.5% | 53.6% | 38.4% |
Return vs Industry: PFIZER underperformed the Indian Pharmaceuticals industry which returned 56% over the past year.
Return vs Market: PFIZER underperformed the Indian Market which returned 41.4% over the past year.
Price Volatility
| PFIZER volatility | |
|---|---|
| PFIZER Average Weekly Movement | 3.4% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in IN Market | 9.8% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: PFIZER has not had significant price volatility in the past 3 months.
Volatility Over Time: PFIZER's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1950 | 1,702 | Meenakshi Nevatia | www.pfizerltd.co.in |
Pfizer Limited engages in manufacturing, marketing, trading, and export of pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas, including neuro/central nervous system, hormones, cardiovascular, hemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastro intestinal, vaccines, respiratory, and vitamins/minerals/nutrients. It sells its products through a network of independent distributors primarily under various brand names.
Pfizer Limited Fundamentals Summary
| PFIZER fundamental statistics | |
|---|---|
| Market cap | ₹196.93b |
| Earnings (TTM) | ₹5.02b |
| Revenue (TTM) | ₹22.19b |
39.2x
P/E Ratio8.9x
P/S RatioIs PFIZER overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PFIZER income statement (TTM) | |
|---|---|
| Revenue | ₹22.19b |
| Cost of Revenue | ₹8.23b |
| Gross Profit | ₹13.96b |
| Other Expenses | ₹8.94b |
| Earnings | ₹5.02b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 17, 2024
| Earnings per share (EPS) | 109.76 |
| Gross Margin | 62.90% |
| Net Profit Margin | 22.63% |
| Debt/Equity Ratio | 3.5% |
How did PFIZER perform over the long term?
See historical performance and comparison